Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: A review

Digestive Diseases and Sciences

Volumn 57, Issue 11, 2012, Pages 2743-2754

  Kalafateli, M ^a   Triantos, C K ^a   Nikolopoulou, V ^a   Burroughs, A ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Gastrointestinal hemorrhage; Liver cirrhosis; Portal hypertension; Review

Indexed keywords

OCTREOTIDE; OMEPRAZOLE; PROPRANOLOL; TERLIPRESSIN; VASOPRESSIN;

ANEMIA; CLINICAL FEATURE; DIEULAFOY DISEASE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ENDOSCOPY; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HEMORRHOID; HUMAN; INCIDENCE; LASER COAGULATION; LIVER CIRRHOSIS; MALLORY WEISS SYNDROME; MULTICENTER STUDY (TOPIC); NEODYMIUM YAG LASER; PEPTIC ULCER; PORTAL HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHUNTING; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH DISEASE; STOMACH LESION; TREATMENT DURATION; ULCER; UPPER GASTROINTESTINAL BLEEDING;

GASTROINTESTINAL HEMORRHAGE; HEMORRHOIDS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALLORY-WEISS SYNDROME; PEPTIC ULCER; STOMACH DISEASES;

EID: 84871612062     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2229-x     Document Type: Review

References (165)

1. Schlichting P, Christensen E, Fauerholdt L, Poulsen H, Juhl E, Tygstrup N. Main causes of death in cirrhosis. Scand J Gastroenterol. 1983;18:881-888.
2. Franco D, Durandy Y, Deporte A, Bismuth H. Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress. Lancet. 1977;1:218-220.
3. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800-809.
4. Christensen E, Krintel JJ, Meltofte Hansen S, Krogh Johansen J, Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognosis. Scand J Gastroenterol. 1989;24:999-1006.
5. Garden OJ, Motyl H, Gilmour WH, Utley RJ, Carter DC. Prediction of outcome following acute variceal haemorrhage. Br J Surg. 1985;72:91-95.
6. Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001;34: 671-676.
7. Navasa M, Rimola A, Rodes J. Bacterial infections in liver disease. Semin Liver Dis. 1997;4:323-333.
8. Runyon BA. Bacterial infections in patients with cirrhosis. J Hepatol. 1993;18:271-272.
9. Burroughs AK, Triantos CK. Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol. 2008; 48:185-188.
10. D'Amico G, DeFranchis R. Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599-612.
11. Afessa B, Kubilis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. American J Gastroenterol. 2000;95:484-489.
12. Primignani M, Carpinelli L, Preatoni P, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology. 2000;119:181-187.
13. D'Amico G, Montanalbo L, Traina M, et al. Natural history of congestive gastropathy in cirrhosis. The liver study group of V. Cervello Hospital. Gastroenterology. 1990;99:1558-1564.
14. Merli M, Nicolini G, Angeloni S, Gentili F, Attili AF, Riggio O. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol. 2004;99:1959-1965.
15. Iwao T, Toyonaga A, Oho K, et al. Portal-hypertensive gastropathy develops less in patients with cirrhosis and fundal varices. J Hepatol. 1997;26:1235-1241.
16. Iwao T, Toyonaga A, Sumino M, et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology. 1992;102: 2060-2065.
17. Fontana R, Sanyal A. The HALT-C trial Group et al. Portal hypertensive gastropathy in chronic Hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C Trial. Am J Gastroenterol. 2006;101:983-992.
18. Sarin S, Sreenivas D, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology. 1992;102:994-999.
19. Sarin S, Misra S, Singal A, Thorat V, Broor S. Evaluation of the incidence and significance of the "Mosaic Pattern" in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Am J Gastroenterol. 1988;83:1235-1239.
20. Franchis De. Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V Consensus workshop on methology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762-768.
21. Loperfido S, Baldo V, Piovesana E, et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc. 2009;70:212-224.
22. Gostout C, Viggiano T, Balm R. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol. 1993;88:2030-2033.
23. Hosking S, Kennedy H, Seddon I, Triger D. The role of propanolol in congestive gastropathy of portal hypertension. Hepatology. 1987;7:437-441.
24. Kouroumalis EA, Koutroubakis IE, Manousos ON. Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol. 1998;10:509-512.
25. Zhou Y, Qiao L, Wu J, Hu H, Xu C. Control of bleeding in portal hypertensive gastropathy: comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy. A controlled study. J Gastroenterol Hepatol. 2002;17:973-979.
26. Bruha R, Marecek Z, Spicak J, et al. Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology. 2002;49: 1161-1166.
27. Mezawa S, Homma H, Ohta H, et al. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol. 2001;96:1155-1159.
28. Kamath P, Lacerda M, Ahlquist D, McKusick MA, Andrews JC, Nagorney DA. Gastric Mucosal Responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterol. 2000;118:905-911.
29. De Franchis R. Portal hypertension II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies. Oxford: Blackwell Science, 1996; 30-55.
30. Perez-Ayuso R, Pique J, Bosch J, et al. Propanolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991;337:1431-1434.
31. Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis. 2011;43:345-351.
32. Panes J, Bordas JM, Pique JM, et al. Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology. 1993;17:213-218.
33. Lo GH, Lai KH, Cheng JS, et al. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. Gastrointest Endosc. 2001;53:579-584.
34. Urata J, Yamashita Y, Tsuchigame T, et al. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol. 1998;118:1061-1067.
35. Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. Am J Roentgenol. 2005;185:472-480.
36. Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992;15:256-263.
37. Payen JL, Calès P, Voigt JJ, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138.
38. Vincent C, Pomier-Layrargues G, Dagenais M, et al. Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transpl. 2002;8:717-720.
39. Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80:1035.
40. Liberski SM, McGarrity TJ, Hartle RJ, Varano V, Reynolds D. The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy. Gastrointest Endosc. 1994;40:584-587.
41. Tobin RW, Hackman RC, Kimmey MB, et al. Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc. 1996;44:223-229.
42. Yamamoto M, Takahashi H, Akaike J, et al. Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol. 2008;37:315-316.
43. Ingraham KM, O'Brien MS, Shenin M, Derk CT, Steen VD. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol. 2010;37:603-607.
44. Spahr L, Villeneuve JP, Dufresne MP, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut. 1999;44:739-742.
45. Ward EM, Raimondo M, Rosser BG, Wallace MB, Dickson RD. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol. 2004;38:898-900.
46. Herman BE, Vargo JJ, Baum S, Silverman ED, Eisold J. Gastric antral vascular ectasia: a case report and review of the literature. J Nucl Med. 1996;37:854.
47. Barnard GF, Colby JM, Saltzman JR, Krims PE, Li L, Banner BF. Endoscopic ultrasound appearance of watermelon stomach. Abdom Imaging. 1995;20:26.
48. Tsai HH, Smith J, Danesh BJ. Successful control of bleeding from gastric antral vascular ectasia (watermelon stomach) by laser photocoagulation. Gut. 1991;32:93-94.
49. Lingenfelser T, Mueller M, Marks IN, Dette S, Wehrman M, Scheurlen M. Endoscopic laser therapy in a case of gastric antral vascular ectasia. Z Gastroenterol. 1993;31:322-324.
50. Yamada M, Nishimura D, Hoshino H, Katada N, Sano H, Kato K. Gastric antral vascular ectasia successfully treated by endoscopic electrocoagulation. J Gastroenterol. 1998;33:546-549.
51. Tominaga K, Arakawa T, Taguchi M, et al. Histological examination of the efficacy of endoscopic laser coagulation therapy for diffuse antral vascular ectasia. Eur J Gastroenterol Hepatol. 2000;12:469-472.
52. Poniachik J, Quera R, Saenz R, Alfaro J, Smok G. Endoscopic coagulation with argon plasma, a therapeutic option in gastric antral vascular ectasia. Rev Med Chil. 2001;129:547-551.
53. Lee BJ, Park JJ, Seo YS, et al. Upper gastrointestinal bleeding from duodenal vascular ectasia in a patients with cirrhosis. World J Gastroenterol. 2007;13:5154-5157.
54. Lecleire S, Ben-Soussan E, Antonietti M, et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc. 2008;67:219-225.
55. Bhatti MA, Khan AA, Alam A, Butt AK, Shafqat F, Malik K. Successful treatment of watermelon stomach/GAVE syndrome by using argon plasma coagulation. J Coll Physicians Surg Pak. 2008;18:641-643.
56. Rosenfeld G, Enns R. Argon photocoagulation in the treatment of gastric antral vascular ectasia and radiation proctitis. Can J Gastroenterol. 2009;23:801-804.
57. Fuccio L, Zagari RM, Serrani M, et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasiarelated bleeding in patients with liver cirrhosis. Digestion. 2009;79:143-150.
58. Bhatti MA, Jhan AA, Alam A, et al. Efficacy of argon plasma coagulation in gastric vascular ectasia in patients with liver cirrhosis. J Coll Physicians Surg Pak. 2009;19:219-222.
59. Wells CD, Harrison ME, Gurudu SR, et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc. 2008;68:231-236.
60. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther. 1999;13: 1429-1436.
61. Tran A, Villeneuve JP, Bilodeau M, et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol. 1999;94:2909-2911.
62. McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42:750-752.
63. Toyota M, Hinoda Y, Nakagawa N, et al. Gastric antral vascular ectasia causing severe anemia. J Gastroenterol. 1996;31:710-713.
64. Estevez P, Jimenez FP. Vascular ectasia of the gastric antrum as the cause of chronic digestive hemorrhage. Presentation of a case. Acta Gastroenterol Latinoam. 1999;29:325-330.
65. Tuveri M, Borsezio V, Gabbas A, Mura G. Gastric antral vascular ectasia-an unusual cause of gastric outlet obstruction: report of a case. Surg Today. 2007;37:503-505.
66. Siringo S, Burroughs AK, Bolondi L, et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol. 1995;22:633-641.
67. Siringo S, Bolondi L, Piscaglia F, et al. Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. Ital J Gastroenterol Hepatol. 1997;29:62-68.
68. Cryer B, Spechler SJ. Peptic ulcer disease. In: Felman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders; 2006:1089-1110.
69. Zullo A, Hassan C, Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fiction. Dig Liver Dis. 2003;35:197-205.
70. Fraser AG, Pounder RE, Burroughs AK. Gastric secretion and peptic ulceration in cirrhosis. J Hepatol. 1993;19:171-182.
71. Marshall BJ. Helicobacter pylori. Am J Gastroenterol. 1994;89: S116-S128.
72. Graham DY, Sung JJ. Helicobacter pylori. In: Felman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders; 2006:1049-1066.
73. Kim DJ, Kim HY, Kim SJ, et al. Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Internal Med. 2008;23:16-21.
74. Siringo S, Vaira D, Menegatti M, et al. High prevalence of Helicobacter pylori in liver cirrhosis. Dig Dis Sci. 1997;42: 2024-2030.
75. Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. J Clin Gastroenterol. 2008;42:744-749.
76. Kitano S, Dolgor B. Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol. 2000;35:79-86.
77. Suzuki H, Ishii H. Peptic ulcer disease complicated with liver cirrhosis. Nippon Rinsho. 2004;62:532-540.
78. Kirk AP, Dooley JS, Hunt RH. Peptic ulceration in patients with liver disease. Dig Dis Sci. 1980;25:756-760.
79. Mitchell CJ, Jewell DP. The diagnosis of the site of upper gastrointestinal haemorrhage in patients with established portal hypertension. Endoscopy. 1977;9:131-135.
80. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Br Med J. 1995;311:222-226.
81. Svoboda P, Ehrmann J, Klvana P, Machytka E, Rydlo M, Hrabovsky V. The etiology of upper gastrointestinal bleeding in patients with liver cirrhosis. Vnitr Lek. 2007;53:1274-1277.
82. Gonzalez-Gonzalez JA, Garcia-Compean D, Vazquez-Elizondo G, Garza-Galindo A, Jaquez-Quintana JO, Maldonado-Garza H. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of inhospital mortality. A prospective study. Ann Hepatol. 2011;10: 287-295.
83. Castro-Fernandez M, Sanchez-Munoz D, Galan-Jurado MV, et al. Influence of nonsteroidal anti-inflammatory drugs in gastrointestinal bleeding due to gastroduodenal ulcers or erosions in patients with liver cirrhosis. Gastroenterol Hepatol. 2006;29: 11-14.
84. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology. (Epub ahead of print). doi:10.1002/hep.25684.
85. Lehnert T, Herfarth C. Peptic ulcer surgery in patients with liver cirrhosis. Ann Surg. 1993;217:338-346.
86. Eidus LB, Rasuli P, Manion D, Heringer R. Caliber persistent artery of the stomach (Dieulafoy's vascular malformation). Gastroenterology. 1990;90:1507-1510.
87. Pathan NF, El-Fanek H. A 70-year-old man with episodes of upper gastrointestinal bleeding. Dieulafoy lesion/malformation. Arch Pathol Lab Med. 2006;130:27-29.
88. Alshumrani G, Almuaikeel M. Angiographic findings and endovascular embolization in Dieulafoy disease: a case report and literature review. Diagn Interv Radiol. 2006;12:151-154.
89. Nga ME, Buhari SA, Iau PT, Raju GC. Jejunal Dieulafoy lesion with massive lower intestinal bleeding. Int J Colorectal Dis. 2007;22:1417-1418.
90. Jain R, Chetty R. Dielafoy disease of the colon. Arch Pathol Lab Med. 2009;133:1865-1867.
91. Ibanez A, Castro E, Fernandez E, et al. Clinical aspects and endoscopic management of gastrointestinal bleeding from Dieulafoy lesion. Rev Esp Enferm Dig. 2007;99:505-510.
92. Juler GL, Labitzke HG, Lamb R, Allen R. The pathogenesis of Dielafoy's gastric erosion. Am J Gastroenterol. 1984; 79:195-200.
93. Broberg A, Ihre T, Pyke E, Raaschou-Nielson T. Exulceration simplex as conceivable cause of massive gastric hemorrhage. Surg Gynecol Obstet. 1982; 154:186-188.
94. Baxter M, Aly EH. Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 2010;92: 548-554.
95. Akhras J, Patel P, Tobi M. Dieulafoy's lesion-like bleeding: An underrecognized cause of upper gastrointestinal hemorrhage in patients with advanced liver disease. Dig Dis Sci. 2007;52:722-726.
96. Baettig B, Haecki W, Lammer F, Jost R. Dieulafoy's disease: endoscopic treatment and follow up. Gut. 1993;34:1418-1421.
97. Mumtaz R, Shaukat M, Ramirez FC. Outcomes of endoscopic treatment of gastroduodenal Dieulafoy's lesion with rubber band ligation and thermal/injection therapy. J Clin Gastroenterol. 2003; 36:310-314.
98. Iacopini F, Petruzzielo L, Marchese M, et al. Hemostasis of Dieulafoy's lesions by argon plasma coagulation. Gastrointest Endosc. 2007;66:20-26.
99. Mallory GK, Weiss S. Hemorrhages from laceration of cardia orifice of the stomach due to vomiting. Am J Med Sci. 1929;178: 506-510.
100. Lecleire S, Di Fiore F, Merle V, et al. Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol. 2005;39:321-327.
101. Di Fiore F, Lecleire S, Merle V, et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol. 2005;17:641-647.
102. Penston JG, Boyd EJ, Wormsley KG. Mallory-Weiss tears occurring during endoscopy: a report of seven cases. Endoscopy. 1992;24:262.
103. Watts HD, Admirand WH. Mallory-Weiss syndrome. A reappraisal. JAMA. 1974;230:1674.
104. Harris JM, DiPalma JA. Clinical significance of Mallory-Weiss tears. Am J Gastroenterol. 1993;88:2056.
105. Michel L, Serrano A, Malt RA. Mallory-Weiss syndrome. Evolution of diagnostic and therapeutic patterns over two decades. Ann Surg. 1980;192:716.
106. Dagradi AE, Broderick JT, Juler G, Wolinsky S, Stempien SJ. The Mallory-Weiss syndrome and lesion. A study of 30 cases. Am J Dig Dis. 1966;11:710.
107. Sugawa C, Benishek D, Walt AJ. Mallory-Weiss syndrome. A study of 224 patients. Am J Surg. 1983;145:30.
108. Knauer CM. Mallory-Weiss syndrome. Characterization of 75 Mallory-Weiss lacerations in 528 patients with upper gastrointestinal hemorrhage. Gastroenterology. 1976;71:5.
109. Paquet KJ, Mercado-Diaz M, Kalk JF. Frequency, significance and therapy of the Mallory-Weiss syndrome in patients with portal hypertension. Hepatology. 1990;11:879-883.
110. Schuman BM, Threadgill ST. The influence of liver disease and portal hypertension on bleeding in Mallory-Weiss syndrome. J Clin Gastroenterol. 1994;18:10-12.
111. Fujisawa N, Inamori M, Sekino Y, et al. Risk factors for mortality in patients with Mallory-Weiss syndrome. Hepatogastroenterology. 2011;58:417-420.
112. Akhtar AJ, Padda MS. Natural history of Mallory-Weiss tear in African American and Hispanic patients. J Natl Med Assoc. 2011;103:412-415.
113. Kortas DY, Haas LS, Simpson WG, Nickl NJ 3rd, Gates LK Jr. Mallory-Weiss tear: predisposing factors and predictors of a complicated course. Am J Gastroenterol. 2001;96:2863-2865.
114. Park CH, Min SW, Sohn YH, et al. A prospective, randomized trial of endoscopic band ligation vs. epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest Endosc. 2004;60:22-27.
115. Terada R, Ito S, Akama F, et al. Mallory-Weiss syndrome with severe bleeding: treatment by endoscopic ligation. Am J Emerg Med. 2000;18:812-815.
116. Higuchi N, Akahoshi K, Sumida Y, et al. Endoscopic band ligation therapy for upper gastrointestinal bleeding related to Mallory-Weiss syndrome. Surg Endosc. 2006;20:1431-1434.
117. Cho YS, Chae HS, Kim HK, et al. Endoscopic band ligation and endoscopic hemoclip placement for patients with Mallory-Weiss syndrome and active bleeding. World J Gastroenterol. 2008;14: 2080-2084.
118. Lecleire S, Antonnieti M, Iwanicki-Caron I, et al. Endoscopic band ligation could decrease recurrent bleeding in Maallory-Weiss syndrome as compared to hemostasis by hemoclips plus epinephrine. Aliment Pharmacol Ther. 2009;30:399-405.
119. Ivekovic H, Rustemovic N, Brkic T, et al. The esophagus as a working channel: successful closure of a large Mallory-Weiss tear with clips and an endoloop. Endoscopy. 2011;43:E170.
120. Wright G, Lewis H, Hogan B, Burroughs A, Patch D, O'Beirne J. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc. 2010;71:71-78.
121. De Palma G, Rega M, Masone S, et al. Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study. Gastrointest Endosc. 2005;62: 529-534.
122. Canlas KR, Dobozi BM, Lin S, et al. Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia. J Clin Gastroenterol. 2008;42: 844-848.
123. Abdelaal UM, Morita E, Nouda S, et al. Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact? J Clin Biochem Nutr. 2010;47:37-44.
124. Higaki N, Matsui H, Imaoka H, et al. Characteristic endoscopic features of portal hypertensive enteropathy. J Gastroenterol. 2008;43:327-331.
125. Menchen L, Ripoll C, Marin-Jimenez I, et al. Prevalence of portal hypertensive duodenopathy in cirrhosis: clinical and hemodynamic features. Eur J Gastroenterol Hepatol. 2006;18: 649-653.
126. Figueiredo P, Almeida N, Lerias C, et al. Effect of portal hypertension in the small bowel: an endoscopic approach. Dig Dis Sci. 2008;53:2144-2150.
127. Jimenez-Saenz M, Romero-Vazquez J, Caunedo-Alvarez A, Maldonado-Perez B, Herrerias Gutierrez JM. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy. Dig Dis Sci. 2010;42:232-233.
128. Zhong J, Ma T, Zhang C, et al. A retrospective study of the application on double-balloon enteroscopy in 378 patients with suspected small bowel diseases. Endoscopy. 2007;39:208-215.
129. Pezzoli A, Fusetti N, Simone L, et al. Portal hypertensive enteropathy diagnosed by capsule endoscopy and demonstration of the ileal changes after transjugular intrahepatic portosystemic shunt placement: a case report. J Med Case Rep. 2011;5:90.
130. Bresci G, Gambardella L, Parisi G, et al. Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol. 1998;26:222-227.
131. Baba HY, Hokotate H, Inoue H, Nakajo M. Correlations between colonic wall thickening in patients with virally induced cirrhosis on CT and clinical status. J Comput Assist Tomogr. 2001;25:786-791.
132. Misra SP, Dwivedi M, Misra V, Dharmani S, Kunwar BK, Arora JS. Colonic changes in patients with cirrhosis and in patients with extrahepatic portal vein obstruction. Endoscopy. 2005;37: 454-459.
133. Kozarek RA, Botoman VA, Bredfeldt JE, Roach JM, Patterson DJ, Ball TJ. Portal colopathy: prospective study of colopathy in patients with portal hypertension. Gastroenterology. 1991;101: 1192-1197.
134. Naveau S, Bedossa P, Poynard T, Mory B, Chaput JC. Portal hypertensive colopathy: a new entity. Dig Dis Sci. 1991;36: 1774-1781.
135. Tam TN, Ng WW, Lee SD. Colonic mucosal changes in patients with liver cirrhosis. Gastrointest Endosc. 1995;42:408-412.
136. Bini EJ, Lascarides CE, Micale PL, Weinshel EH. Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study. Gastrointest Endosc. 2000;52:511-516.
137. Ito K, Shiraki K, Sakai T, Yoshimura H, Nakano T. Portal hypertensive colopathy in patients with liver cirrhosis. World J Gastroenterol. 2005;11:3127-3130.
138. Bresci G, Parisi G, Capria A. Clinical relevance of colonic lesions in cirrhotic patients with portal hypertension. Endoscopy. 2006;38:830-835.
139. Chen LS, Lin HC, Lee FY, Hou MC, Lee SD. Portal hypertensive colopathy in patients with cirrhosis. Scand J Gastroenterol. 1996;31:490-494.
140. Diaz-Sanchez A, Nunez-Martinez O, Gonzalez-Asanza C, et al. Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients. World J Gastroenterol. 2009;15:4781-4787.
141. Yoshie K, Fujita Y, Moriya A, Kawana I, Miyamoto K, Umemura S. Octreotide for severe acute bleeding from portal hypertensive colopathy: a case report. Eur J Gastroenterol Hepatol. 2001;13: 1111-1113.
142. Santoro GA, Aiello C, Galloro G, Savino N, Bucci L. Massive lower gastrointestinal hemorrhage in patients with portal hypertensive enteropathy: a report of two case. Hepatogastroenterology. 1997;44:1029-1032.
143. Rana SS, Dutta U, Sinha SK, Kochhar R, Nagi B, Bhasin DK. Severe acute bleeding from portal colopathy controlled by somatostatin. Trop Gastroenterol. 2004;25:144-145.
144. Bernard AC, Hagihara PF, Burke VJ, Kugelmas M. Endoscopic localization and management of colonic bleeding in patients with portal hypertension. Surg Laparosc Endosc Percutan Tech. 2001;11:195-198.
145. Ohta M, Hashizume M, Kishihara F, Kawanaka H, Tanoue K, Sugimachi K. Recurrent rectal bleeding from portal hypertensive colopathy in a patient with hemorrhoids. Am J Gastroenterol. 1995;90:1531-1533.
146. Balzer C, Lotterer E, Kleber G, Fleig WE. Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal hypertensive colopathy. Gastroenterology. 1998;115: 167-172.
147. Ozgediz D, Devine P, Garcia-Aquilar J. Refractory lower gastrointestinal bleeding from portal hypertensive colopathy. J Am Coll Surg. 2008;207:613.
148. Misra SP, Dwivredi M, Misra V. Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension. Endoscopy. 1996;28:340-345.
149. Misra SP, Misra V, Dwivedi M. Effect of esophageal variceal band ligation on hemorrhoids, anorectal varices, and portal hypertensive gastropathy. Endoscopy. 2002;34:195-198.
150. Wang TF, Lee FY, Tsai YT, et al. Relationship of portal pressure, anorectal varices and hemorrhoids in cirrhotic patients. J Hepatol. 1992;15:170-173.
151. Rabinovitz M, Schade RR, Dindzans VJ, Belle SH, Van Thiel DH, Gavaler JS. Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. Gastroenterology. 1990;99:195-199.
152. Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol. 1999;94:895-899.
153. Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology. 1990;98:380-386.
154. Hegedus L, Ladocsi B, Wellner I, Olah A. New surgical method in the treatment of severe hemorrhoidal bleeding caused by decompensated liver cirrhosis. Megy Seb. 2001;54:52-53.
155. Huang WS, Lin PY, Chin CC, et al. Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience. Int J Colorectal Dis. 2007;22:1083-1089.
156. Zaher T, Ibrahim I, Ibrahim A. Endoscopic band ligation of internal hemorrhoids versus stapled hemorrhoidopexy in patients with portal hypertension. Arab J Gastroenterol. 2011;12:11-14.
157. Franco D, Deporte A, Darragon T, Bismuth H. Digestive tract hemorrhages of cirrhotic patients. Relation between hepatic insufficiency and the hemorrhagic lesion. Nouv Presse Med. 1975;4:2993-2996.
158. Teres J, Bordas JM, Bru C, Diaz F, Bruguera M, Rodes J. Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations. Gut. 1976;17:37-40.
159. Hsieh WJ, Lin HC, Hwang SJ, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol. 1998; 93:962-966.
160. Del Olmo JA, Pena A, Serra MA, Wassel AH, Benages A, Rodrigo JM. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol. 2000;32:19-24.
161. Odelowo O, Smoot D, Kim K. Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc. 2002; 9.
162. Vlachogiannakos J, Sklavos P, Viazis N et al. Long-term prognosis of cirrhotics with an upper gastrointestinal bleeding episode: Does infection play a role? J Gastroenterol Hepatol. 2008; 23:e438-e444.
163. Seo YS, Kim YH, Ahn SH, et al. Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci. 2008;23:635-643.
164. Thabut D, D'Amico G, Tan P, et al. Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. J Hepatol. 2010;53:1029-1034.
165. Svoboda P, Ehrmann J, Klvana P, Machytka E, Rydlo M, Hrabovsky V. Adifferent view of acute upper gastrointestinal bleeding in liver cirrhosis patients. Vnitr Lek. 2010;56:1116-1121.